FDA Warns Consumers Against 'Hard AF!' Sexual Enhancement Supplement Containing Hidden Prescription Drugs

The U.S. Food and Drug Administration (FDA) has identified 'Hard AF!', a product marketed as a dietary supplement for sexual enhancement, as containing two undeclared prescription drug ingredients: sildenafil and tadalafil. Both are active ingredients in prescription medications—sildenafil in Viagra and tadalafil in Cialis—used to treat erectile dysfunction under medical supervision. The FDA issued this public notification in response to the discovery that consumers purchasing 'Hard AF!' are unknowingly ingesting prescription drugs without medical oversight, creating significant health risks. The warning highlights a persistent enforcement challenge: dietary supplements that illegally contain pharmaceutical ingredients and are sold without proper labeling or safety warnings.

What Happened

The FDA identified 'Hard AF!' as a product being sold as a dietary supplement while containing sildenafil and tadalafil, neither of which appeared on the product label. Because these ingredients are prescription medications under federal law, any product containing them without FDA approval for that formulation is considered an unapproved drug, not a dietary supplement. Manufacturers of 'Hard AF!' exploited the lower regulatory pathway for supplements—which do not require pre-market FDA approval under the Dietary Supplement Health and Education Act (DSHEA)—to bring a pharmaceutical product to market without undergoing drug approval processes.

The undeclared nature of the ingredients prevents consumers from making informed decisions about safety or potential interactions with their other medications and medical conditions. Healthcare providers similarly cannot identify the hidden drugs when treating patients who may experience adverse events, complicating medical management and preventing proper reporting to safety monitoring systems.

What the Source and Research Say

According to the FDA's public safety notification system, products containing hidden prescription ingredients represent a significant and persistent public health threat. Sildenafil and tadalafil are selective phosphodiesterase-5 (PDE-5) inhibitors that work by relaxing smooth muscle in blood vessels and increasing blood flow. While these drugs are effective for erectile dysfunction when prescribed and monitored by healthcare providers, they carry substantial contraindications and potential side effects that require medical assessment.

Documented adverse effects of sildenafil and tadalafil include sudden drops in blood pressure, headache, flushing, indigestion, vision disturbances (including blue-tinted vision), and in rare cases, priapism—a prolonged, painful erection requiring emergency intervention. Vision loss has also been reported. The cardiovascular risk escalates significantly when these drugs interact with nitrates (commonly prescribed for angina and coronary artery disease), alpha-blockers used for hypertension and prostate conditions, or other blood-pressure-lowering medications. FDA guidance on dietary supplement safety identifies products spiked with prescription drugs as a category of particular enforcement concern because consumers cannot assess their individual risk factors or monitor for dangerous drug-drug interactions.

Beyond the Headline

'Hard AF!' exemplifies a longstanding enforcement challenge in the dietary supplement market. The FDA has documented dozens of cases involving sexual enhancement supplements, weight-loss products, and sports supplements adulterated with sildenafil, tadalafil, phenibut, sibutramine, or other pharmaceutical ingredients. Because supplements do not require pre-market approval, deceptive manufacturers can reach consumers quickly at low cost, then disappear before FDA enforcement action is completed.

The supplement industry's self-regulation mechanisms—including voluntary standards from the Natural Products Association and other trade groups—have proven insufficient to prevent these violations. Third-party testing programs (such as USP, NSF, and ConsumerLab) provide some assurance but do not test all products, and their certification is voluntary. Enforcement ultimately depends on FDA inspections, consumer complaints, and adverse event reports submitted through the MedWatch system. The regulatory burden for identifying and removing adulterated products falls heavily on FDA resources, which are stretched across a $6 trillion supplement market with limited inspection capacity.

What This Means for Consumers

Consumers should immediately discontinue use of 'Hard AF!' and safely dispose of any remaining product. If you have used this supplement and experienced sudden vision changes, severe headache, chest pain, fainting, or a sustained erection lasting longer than four hours, seek emergency medical attention immediately and inform your healthcare provider that the product contained undeclared sildenafil and tadalafil.

For individuals seeking treatment for erectile dysfunction, prescription medications are available through licensed pharmacies with a healthcare provider's prescription. A doctor can review your complete medical history, current medications, and individual risk factors to determine whether sildenafil or tadalafil is appropriate, and at what dose. This medical oversight is critical for safety and cannot be replicated by self-treatment with unlabeled supplements.

When shopping for dietary supplements—especially those marketed for sexual enhancement, weight loss, or athletic performance—follow these evidence-based practices: (1) Purchase only from reputable manufacturers with transparent ingredient labeling verified on the product label and website. (2) Look for third-party testing seals from USP, NSF, or ConsumerLab, which indicate independent verification of contents. (3) Cross-reference the product name against the FDA's public notification database and recalls before purchasing. (4) Avoid products with vague marketing claims like "enhances performance" or "boosts vitality," unusually low prices compared to established brands, or sources limited to unverified online retailers. (5) Always inform your healthcare provider about any supplements you are considering or currently taking, especially if you have cardiovascular disease, take blood pressure medications, or use nitrate medications.

What to Watch Next

The FDA typically follows public notifications with enforcement actions, which may include seizure of remaining product stock, import alerts preventing future shipments, or warning letters and civil/criminal penalties against the manufacturers and distributors of 'Hard AF!'. Consumers who have purchased the product are encouraged to report adverse events through the FDA's MedWatch system online or by phone at 1-888-SAFEFDA.

Future enforcement updates may identify the distribution channels through which 'Hard AF!' was sold (online retailers, convenience stores, gas stations), the manufacturer's location and business structure, and any criminal charges filed. At the broader policy level, the FDA's ongoing modernization efforts aim to strengthen supplement oversight through potential legislative changes, including mandatory manufacturer registration, expanded recall authority, and stricter pre-market safety requirements for novel supplement ingredients. Until such changes occur, checking the FDA's public notification database remains the primary consumer defense against adulterated products.